Clinical Trial Update: Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of ABI-009 in non-muscle invasive bladder cancer completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• ABI-009

Snippet

Sponsor: Aadi Bioscience, Inc. | Conditions: Non-muscle Invasive Bladder Cancer (NMIBC) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-06-08